• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Computational analysis of adaptive antigenic mutations of the human influenza hemagglutinin for vaccine strain selection

tetano

Editor, Senior Moderator
Int J Bioinform Res Appl. 2012;8(1):81-98.
Computational analysis of adaptive antigenic mutations of the human influenza hemagglutinin for vaccine strain selection.
Rickert JD, Herpy TA, Zhong H, Lu G.
Source

Department of Biology, University of Nebraska-Omaha, Omaha, NE 68182, USA.
Abstract

The adaptive evolution of the hemagglutinin (HA) segment of the human influenza H1N1 and H3N2 viruses is not well understood due to antigenic mutations under selection pressures. This paper identified significant antigenic selection sites and discussed the structural relevance of these mutations. We discovered four positively selected sites for H1N1 (position 206 for the 1A lineage - 2009 swine influenza, and positions 144, 190, and 192 for the 1B lineage), and eight positively selected sites for H3N2 with the loop regions near residues 157 and 225 as the latest antigenic mutations, which may be targeted for vaccine development.

PMID:
22450272
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/22450272
 
Back
Top Bottom